NK Cell Trafficking in Health and Autoimmunity:A Comprehensive Review

Clinical Reviews in Allergy and Immunology

Volumn 47, Issue 2, 2014, Pages 119-127

  Peng, Hui ^a   Tian, Zhigang ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Autoimmune diseases; Natural killer cells; Steady state; Trafficking

Indexed keywords

EID: 84890489532     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-013-8400-0     Document Type: Review

References (109)

1. Ljunggren HG, Malmberg KJ (2007) Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7:329–339
2. French AR, Yokoyama WM (2003) Natural killer cells and viral infections. Curr Opin Immunol 15:45–51
3. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9:503–510
4. Vivier E, Raulet DH, Moretta A et al (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331:44–49
5. Raulet DH, Vance RE (2006) Self-tolerance of natural killer cells. Nat Rev Immunol 6:520–531
6. Raulet DH (2006) Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol 18:145–150
7. Flodstrom-Tullberg M, Bryceson YT, Shi FD, Hoglund P, Ljunggren HG (2009) Natural killer cells in human autoimmunity. Curr Opin Immunol 21:634–640
8. Jost S, Altfeld M (2013) Control of human viral infections by natural killer cells. Annu Rev Immunol 31:163–194
9. Cerwenka A, Lanier LL (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol 1:41–49
10. Cheng M, Chen Y, Xiao W, Sun R, Tian Z (2013) NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 10:230–252
11. Tian Z, Gershwin ME, Zhang C (2012) Regulatory NK cells in autoimmune disease. J Autoimmun 39:206–215
12. Johansson S, Berg L, Hall H, Hoglund P (2005) NK cells: elusive players in autoimmunity. Trends Immunol 26:613–618
13. Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG (2002) The natural killer cell—friend or foe in autoimmune disease? Scand J Immunol 55:432–441
14. Perricone R, Perricone C, De Carolis C, Shoenfeld Y (2008) NK cells in autoimmunity: a two-edged weapon of the immune system. Autoimmun Rev 7:384–390
15. Shi FD, Ljunggren HG, La Cava A, Van Kaer L (2011) Organ-specific features of natural killer cells. Nat Rev Immunol 11:658–671
16. Gregoire C, Chasson L, Luci C et al (2007) The trafficking of natural killer cells. Immunol Rev 220:169–182
17. Peng H, Jiang X, Chen Y et al (2013) Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest 123:1444–1456
18. Vosshenrich CA, Garcia-Ojeda ME, Samson-Villeger SI et al (2006) A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 7:1217–1224
19. Takeda K, Cretney E, Hayakawa Y et al (2005) TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105:2082–2089
20. Yadi H, Burke S, Madeja Z, Hemberger M, Moffett A, Colucci F (2008) Unique receptor repertoire in mouse uterine NK cells. J Immunol 181:6140–6147
21. Croy BA, van den Heuvel MJ, Borzychowski AM, Tayade C (2006) Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones. Immunol Rev 214:161–185
22. Sun H, Sun C, Tian Z, Xiao W (2013) NK cells in immunotolerant organs. Cell Mol Immunol 10:202–212
23. Huntington ND, Vosshenrich CA, Di Santo JP (2007) Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 7:703–714
24. Maghazachi AA (2010) Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 341:37–58
25. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314
26. Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272:60–66
27. Cyster JG (2005) Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 23:127–159
28. Kansas GS (1996) Selectins and their ligands: current concepts and controversies. Blood 88:3259–3287
29. Marelli-Berg FM, Cannella L, Dazzi F, Mirenda V (2008) The highway code of T cell trafficking. J Pathol 214:179–189
30. Kumar V, Ben-Ezra J, Bennett M, Sonnenfeld G (1979) Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration. J Immunol 123:1832–1838
31. Seaman WE, Blackman MA, Gindhart TD, Roubinian JR, Loeb JM, Talal N (1978) beta-Estradiol reduces natural killer cells in mice. J Immunol 121:2193–2198
32. Kim S, Iizuka K, Kang HS et al (2002) In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3:523–528
33. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113:5488–5496
34. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, Di Santo JP (2001) Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 31:1900–1909
35. Huntington ND, Tabarias H, Fairfax K et al (2007) NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol 178:4764–4770
36. Hayakawa Y, Smyth MJ (2006) CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176:1517–1524
37. Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633–640
38. Caligiuri MA (2008) Human natural killer cells. Blood 112:461–469
39. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ (2006) Functional subsets of mouse natural killer cells. Immunol Rev 214:47–55
40. Hayakawa Y, Andrews DM, Smyth MJ (2010) Subset analysis of human and mouse mature NK cells. Methods Mol Biol 612:27–38
41. Wu X, Chen Y, Wei H, Sun R, Tian Z (2012) Development of murine hepatic NK cells during ontogeny: comparison with spleen NK cells. Clin Dev Immunol 2012:759765
42. Fehniger TA, Cooper MA, Nuovo GJ et al (2003) CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101:3052–3057
43. Ferlazzo G, Thomas D, Lin SL et al (2004) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172:1455–1462
44. Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2:656–663
45. Robertson MJ (2002) Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71:173–183
46. Jiang D, Liang J, Hodge J et al (2004) Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 114:291–299
47. Wendel M, Galani IE, Suri-Payer E, Cerwenka A (2008) Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res 68:8437–8445
48. Campbell JJ, Qin S, Unutmaz D et al (2001) Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166:6477–6482
49. Hamann I, Unterwalder N, Cardona AE et al (2011) Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology 133:62–73
50. Sciume G, De Angelis G, Benigni G et al (2011) CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. Blood 117:4467–4475
51. Garcia GE, Xia Y, Chen S et al (2000) NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J Leukoc Biol 67:577–584
52. Huang D, Shi FD, Jung S et al (2006) The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 20:896–905
53. Chen Q, Wei H, Sun R, Zhang J, Tian Z (2008) Therapeutic RNA silencing of Cys-X3-Cys chemokine ligand 1 gene prevents mice from adenovirus vector-induced acute liver injury. Hepatology 47:648–658
54. Pereira JP, An J, Xu Y, Huang Y, Cyster JG (2009) Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat Immunol 10:403–411
55. Jenne CN, Enders A, Rivera R et al (2009) T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med 206:2469–2481
56. Mayol K, Biajoux V, Marvel J, Balabanian K, Walzer T (2011) Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking. Blood 118:4863–4871
57. Ponzetta A, Sciume G, Benigni G et al (2013) CX3CR1 regulates the maintenance of KLRG1+ NK cells into the bone marrow by promoting their entry into circulation. J Immunol 191:5684–5694
58. Bernardini G, Sciume G, Bosisio D, Morrone S, Sozzani S, Santoni A (2008) CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood 111:3626–3634
59. Inngjerdingen M, Damaj B, Maghazachi AA (2001) Expression and regulation of chemokine receptors in human natural killer cells. Blood 97:367–375
60. Broxmeyer HE, Orschell CM, Clapp DW et al (2005) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201:1307–1318
61. Beider K, Nagler A, Wald O et al (2003) Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood 102:1951–1958
62. Walzer T, Chiossone L, Chaix J et al (2007) Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 8:1337–1344
63. Spiegel S, Milstien S (2011) The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11:403–415
64. Cyster JG, Schwab SR (2012) Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 30:69–94
65. Chen S, Kawashima H, Lowe JB, Lanier LL, Fukuda M (2005) Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J Exp Med 202:1679–1689
66. Bajenoff M, Breart B, Huang AY et al (2006) Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 203:619–631
67. Frey M, Packianathan NB, Fehniger TA et al (1998) Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 161:400–408
68. Juelke K, Killig M, Luetke-Eversloh M et al (2010) CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 116:1299–1307
69. Peng H, Sun R, Tang L, Wei H, Tian Z (2013) CD62L is critical for maturation and accumulation of murine hepatic NK cells in response to viral infection. J Immunol 190:4255–4262
70. Baekkevold ES, Yamanaka T, Palframan RT et al (2001) The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med 193:1105–1112
71. Berahovich RD, Lai NL, Wei Z, Lanier LL, Schall TJ (2006) Evidence for NK cell subsets based on chemokine receptor expression. J Immunol 177:7833–7840
72. O’Leary JG, Goodarzi M, Drayton DL, von Andrian UH (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7:507–516
73. Paust S, Gill HS, Wang BZ et al (2010) Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 11:1127–1135
74. Geissmann F, Cameron TO, Sidobre S et al (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3:e113
75. Jiang X, Chen Y, Peng H, Tian Z (2013) Memory NK cells: why do they reside in the liver? Cell Mol Immunol 10:196–201
76. Hao J, Liu R, Piao W et al (2010) Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 207:1907–1921
77. Bielekova B, Catalfamo M, Reichert-Scrivner S et al (2006) Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 103:5941–5946
78. Infante-Duarte C, Weber A, Kratzschmar J et al (2005) Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J 19:1902–1904
79. von Andrian UH, Engelhardt B (2003) Alpha4 integrins as therapeutic targets in autoimmune disease. N Engl J Med 348:68–72
80. Gan Y, Liu R, Wu W, Bomprezzi R, Shi FD (2012) Antibody to alpha4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis. J Neuroimmunol 247:9–15
81. Conigliaro P, Scrivo R, Valesini G, Perricone R (2011) Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. Autoimmun Rev 10:577–581
82. Pridgeon C, Lennon GP, Pazmany L, Thompson RN, Christmas SE, Moots RJ (2003) Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright, CD94bright, CD158negative phenotype. Rheumatology (Oxford) 42:870–878
83. Dalbeth N, Gundle R, Davies RJ, Lee YC, McMichael AJ, Callan MF (2004) CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 173:6418–6426
84. Mack M, Bruhl H, Gruber R et al (1999) Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 42:981–988
85. Iwamoto T, Okamoto H, Toyama Y, Momohara S (2008) Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 275:4448–4455
86. Joosten LA, Netea MG, Kim SH et al (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 103:3298–3303
87. Park YE, Kim GT, Lee SG et al (2013) IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models. Rheumatol Int 33:671–679
88. Parolini S, Santoro A, Marcenaro E et al (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109:3625–3632
89. Wittamer V, Franssen JD, Vulcano M et al (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198:977–985
90. Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354:54–66
91. Wang HX, Liu M, Weng SY et al (2012) Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J Gastroenterol 18:119–125
92. Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z (2005) Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat 12:38–45
93. Wald O, Weiss ID, Wald H et al (2006) IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 176:4716–4729
94. Wang J, Xu J, Zhang W, Wei H, Tian Z (2005) TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver. Cell Mol Immunol 2:449–453
95. Hudspeth K, Pontarini E, Tentorio P et al. (2013) The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun 46:55-65
96. Chuang YH, Lian ZX, Tsuneyama K et al (2006) Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 26:232–240
97. Chuang YH, Lian ZX, Cheng CM et al (2005) Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun 25:126–132
98. Isse K, Harada K, Zen Y et al (2005) Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 41:506–516
99. van Helden MJ, Zaiss DM, Sijts AJ (2012) CCR2 defines a distinct population of NK cells and mediates their migration during influenza virus infection in mice. PLoS One 7:e52027
100. Martin-Fontecha A, Thomsen LL, Brett S et al (2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5:1260–1265
101. Watt SV, Andrews DM, Takeda K, Smyth MJ, Hayakawa Y (2008) IFN-gamma-dependent recruitment of mature CD27(high) NK cells to lymph nodes primed by dendritic cells. J Immunol 181:5323–5330
102. Liu Q, Smith CW, Zhang W, Burns AR, Li Z (2012) NK cells modulate the inflammatory response to corneal epithelial abrasion and thereby support wound healing. Am J Pathol 181:452–462
103. Okamura A, Harada K, Nio M, Nakanuma Y (2013) Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia. J Clin Pathol 66:99–108
104. El-Shazly AE, Doloriert HC, Bisig B, Lefebvre PP, Delvenne P, Jacobs N (2013) Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue. Clin Exp Allergy 43:322–331
105. Hong HS, Ahmad F, Eberhard JM et al (2012) Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16(+) NK cell-like phenotype and correlates with HIV viral load. PLoS One 7:e44820
106. Cooley S, Xiao F, Pitt M et al (2007) A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 110:578–586
107. Yu J, Mao HC, Wei M et al (2010) CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 115:274–281
108. Castriconi R, Dondero A, Bellora F et al (2013) Neuroblastoma-derived TGF-beta1 modulates the chemokine receptor repertoire of human resting NK cells. J Immunol 190:5321–5328
109. Eisenhardt M, Glassner A, Kramer B et al (2012) The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C. PLoS One 7:e38846